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Introduction
High-throughput sequencing (HTS) has proven to be highly 
successful at identifying causal variants for many genetic 
disorders with a variety of underlying genetic etiologies 
(Boycott et al. 2013). This includes genetic disorders seg-
regating in clear dominant and recessive inheritance modes, 
but also disorders that are caused by less well-studied 
genetic models such as de novo mutations. HTS has also 
been successfully applied to small cohort studies, even in 
the presence of locus heterogeneity (Riviere et al. 2012). 
HTS can potentially identify all causal variants, hence 
cohorts of unrelated individuals with different causal alleles 
are very powerful for the implication of a causal gene since 
the accumulation of rare, likely pathogenic variants in a 
single gene, gene family or pathway, is highly unlikely, 
even for just a few affected individuals.
HTS has identified variants that cause germline Mende-
lian disorders (Ng et al. 2010a, b) segregating in a highly 
penetrant manner, expediting the discovery of many such 
variants (Heron et al. 2012). Such diseases often come 
to notice because they segregate in one or more families. 
Prior to the HTS era, linkage analysis, or other identity by 
descent (IBD) approaches were applied to identify genomic 
regions of interest where the affected status co-segregates 
with genotypic status. The application of HTS has resolved 
several such Mendelian disorders that had achieved prom-
ising linkage results, including highly significant linkage 
results (parametric LOD scores >3), and were awaiting 
causal gene discovery (Corbett et al. 2010, 2011; Koene-
koop et al. 2012; Reversade et al. 2009). As such, iden-
tification of a causal gene for a genetic disorder before 
the advent of HTS usually required a two-step process, 
with the first step being a genome-wide, or chromosome-
wide, localization step, utilizing IBD information inferred 
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through co-segregation of genetic markers such as micros-
atellites and single-nucleotide polymorphisms (SNPs) with 
disease (linkage analysis). The second step consisted of 
the actual identification of the causal variant with Sanger 
sequencing making this task manageable by focusing the 
search on a particular genomic region, usually only a few 
Megabases in length. Genome-wide significant linkage was 
usually required before traditional Sanger sequencing com-
menced, but without any obvious candidate genes this could 
then lead to the laborious sequencing of all genes (50–100, 
depending on the size and location of the linkage region) in 
the region, potentially taking years before a causal variant 
and gene were found. HTS has led to an expedition of the 
discovery of causal variants by circumventing the gene by 
gene sequencing step (Fig. 1). Furthermore, since the HTS 
approach is now most cost-effectively performed genome-
wide, via approaches such as whole exome sequencing 
(WES), the first step of genomic localization has been 
seen as unnecessary and more often bypassed. Probands of 
small families may then be contributed to consortium stud-
ies where they are treated as singletons, ignoring the family 
information.
HTS has also been applied successfully to identify 
causal mutations in a number of different genetic models 
including those not previously amenable to analysis. This 
includes de novo germline mutations (Epi4K Consortium 
et al. 2013; Jiang et al. 2013; Lim et al. 2013). Sporadic 
mutations benefit from the application of the trio approach, 
where variants inherited from the parents are eliminated to 
identify the novel mutations in the proband. This has led 
to new insights into the genetic basis of complex disor-
ders such as autism and other neuropsychiatric disorders, 
leading to further debates about the role of such variants 




Fig. 1  Identification of a causal variant in a family study, a prior to 
the advent of HTS, using linkage and Sanger sequencing, b advent 
of HTS, using only a proband, or one or two individuals from a fam-
ily, ignoring relationships between the individuals, leading to lengthy 
lists of putative causal variants, and c mature HTS analysis, where 
family information is incorporated using genotypes derived from 
HTS data to perform a linkage or IBD analysis, leading to a much 
reduced list of variants
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somatic variants (Baek et al. 2013; Lee et al. 2012; Poduri 
et al. 2012) have also been identified. This is another 
genetic model that was intractable prior to HTS and high-
lights the possibility that somatic variants may play a hith-
erto underestimated role in causing genetic disease outside 
the cancer arena.
In germline Mendelian disorders HTS has been most 
successful for recessive disorders, in particular autozy-
gous disorders, which are caused by single mutations. 
Causes of dominant disorders continue to be more resist-
ant to discovery for several reasons. Heterozygous variants 
are harder to call as variants than homozygous alternative 
variants because the binomial variation of reads with par-
ticular alleles is higher for the heterozygote than for the 
two homozygous states. Furthermore, individuals have 
more heterozygous than homozygous novel rare variant 
alleles, making it more difficult to filter out novel benign 
polymorphisms. This is particularly problematic in popula-
tions that are not well represented in databases, where even 
large numbers of novel, nonsynonymous autozygous vari-
ants may remain (Azmanov et al. 2013) after filtering using 
standard databases. Proof that such discovered variants are 
not population polymorphisms can require the sequencing 
of many candidate variants in a relevant population sample 
which is time consuming and costly.
The advent of HTS saw the need for the development 
of pipelines to handle the tens of thousands of variants that 
are routinely called in human genomes. These pipelines 
are still mainly based on single sample/individual analy-
sis, hence the incorporation of familial information is not 
routine. Even when familial information has been avail-
able for use in conjunction with HTS data it is not always 
used, despite the potential for IBD or linkage information 
to add a powerful filter for detected variants. Familial infor-
mation is often included in a very indirect way by apply-
ing a genotyping filter, based on an inferred genetic model 
from the pedigree, with specific genotype assumptions for 
unaffected individuals, carriers, non-carriers and affected 
individuals.
HTS studies are highly reliant on ascribing likely 
pathogenicity according to mutational databases such 
as the Leiden Open Variation Database (LOVD, http:// 
www.LOVD.nl/), The Human Gene Mutation Data-
base (HGMD, http://www.hgmd.cf.ac.uk/) and ClinVar 
(https://www.ncbi.nlm.nih.gov/clinvar/). However, these 
databases are known to be incomplete, missing known 
mutations. Additionally, Bell et al. (2011) showed that 
25 % of variants, described as causal in mutation data-
bases, were low frequency polymorphisms and not 
causal, highlighting the need to assess candidate variants 
further, gathering additional evidence for likely causal-
ity. Early HTS studies were not always required to pro-
vide additional data to support variant discoveries, such 
as multiple mutations in the same gene or functional 
work or evidence of causality in an experimental model 
(Piton et al. 2013). Hence, there is a need to reconsider 
current HTS analysis methodology. One way forward 
is to make greater use of additional information such as 
that afforded by familial information to provide greater 
protection from false positive findings. Many more HTS 
studies remain unpublished because a causal variant has 
failed to be identified. These studies may benefit from 
the approaches discussed here, potentially highlighting a 
hitherto unpromising variant due to the current, perhaps 
limited, understanding of the gene’s biological role, or 
at least highlighting regions in the genome that require 
greater scrutiny, perhaps with supplemental sequencing, 
or generation and analysis of a second attempt at WES, 
with a newer, more comprehensive exome capture plat-
form, or performing WGS.
Here, we describe a set of observations for the analysis 
of both single and familial HTS data that can and should 
be used to help in the identification of the causal variant. 
Making use of familial and population-based informa-
tion for HTS data helps by: (1) extending quality control 
(QC) steps, (2) identifying IBD regions, (3) validating the 
genetic model, and (4) validating haplotype segregation by 
making use of IBD information, with or without additional 
SNP chip data. Using this type of information can lead to 
the accumulation of evidence in favor of particular variants, 
determine the correct genetic model, lead to the elimination 
of irrelevant variants and can also narrow the search space 
for variants to particular genomic regions.
HTS data is highly non-uniform in coverage which 
is influenced by GC content of the underlying sequence 
where both very high and very low GC content DNA 
sequence is captured by fewer HTS reads (Dohm et al. 
2008). In addition, this known effect can be exacerbated by 
technology such as exome capture, or by additional biolog-
ical signals such as DNA source. An example of the latter 
is the DNA fragmentation present in cell-free DNA which 
displays DNA motif bias (Chandrananda et al. 2014). This 
bias leads to areas of the genome that are difficult to inter-
rogate with HTS which may require higher coverage, mul-
tiple HTS applications or necessitates improvements in 
HTS technology to be able to be sequenced to a sufficient 
depth to detect variants. Thus, by identifying regions of the 
genome that have been detected as IBD researchers become 
aware of regions that deserve greater scrutiny, possibly also 
for more unusual forms of genetic variation.
Therefore, rather than being relegated to history, IBD 
methods should be recognized as providing a powerful ally 
for HTS to help identify causal variants. We wish to remind 
researchers of the availability of these approaches, outlin-
ing some resources, which could be applied to help solve 
their HTS study.
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Extracting HapMap SNPs from HTS data
Many HTS studies are applied to multiple related individu-
als, with filtering of variants from all the individuals, ignor-
ing familial relationships. One reason for this approach and 
its increasing popularity is the decreasing cost and bulk 
production of HTS data. This often sees researchers forgo-
ing SNP chip data generation and traditional linkage map-
ping approaches, even when the family has sufficient power 
to produce genome-wide significant linkage. However, it 
is possible to extract SNPs from HTS data by instructing 
variant callers to genotype variants at HapMap SNP posi-
tions to create pseudo SNP chip data for all individuals that 
underwent HTS. Hence linkage analysis and other analyses 
can still be performed successfully.
Instructions on how to call HapMap SNPs from HTS 
data, including methods to process this data into linkage 
and IBD analysis ready files can be obtained via http:// 
bioinf.wehi.edu.au/software/linkdatagen. The methods are 
described in Smith et al. (2011) and Bahlo and Bromhead 
(2009). Any genome-wide (or chromosome wide) HTS 
data suffices, as long as enough HapMap SNPs are cov-
ered sufficiently to allow genotype calling. The workflow 
required is more complicated but is not difficult to imple-
ment (Fig. 2).
WES by definition captures mainly exonic DNA. 
Exonic regions are known to have more SNPs that 
undergo balancing selection leading to lower MAFs on 
average (1000 Genomes Project Consortium et al. 2010), 
thus genotyping data from WES will not be as useful for 
IBD and linkage analysis as SNP chips or even genotyp-
ing data extracted from comparable median coverage 
WGS to the median coverage WES data (targeted areas 
only). Table 1 outlines the numbers of HapMap SNPs 
that are called with ≥10× coverage in more than 50 % 
of samples using one WES capture platform in current 
use (Agilent V5 + UTR). This shows the availability of 
tens of thousands of SNPs for linkage and IBD analy-
sis. Many IBD and linkage analyses make use of only 
~10,000 SNPs due to the constraints of linkage equilib-
rium that are imposed to satisfy the first-order Markov 
models that underpin most of these methods. In Smith 
et al. (2011), we compare genome-wide LOD scores 
derived from SNPs genotyped from the Illumina TruSeq 
capture platform to those derived from a high-density 
SNP chip, showing very few differences in the linkage 
analysis results. Inbreeding inference utilizing HTS gen-
otypes is also possible with FSuite (Gazal et al. 2014), 
showing good performance.
Additional quality control steps with familial HTS data
The bulk processing and high-throughput nature of HTS 
usually necessitates batching of samples, which is often 
accomplished through molecular barcoding. The generation 
Fig. 2  Dual workflow for 
HTS data analysis that takes 
advantage of HapMap SNPs 
for linkage mapping (a), and 
then uses this information in the 
filtering steps in (b)
(a) (b)
1335Hum Genet (2014) 133:1331–1341 
1 3
of input for HTS platforms is thus a source of potential 
error with sample mix-ups or mishaps in the sequenc-
ing library preparation step that can lead to contaminated 
samples. As such it is important to check sample veracity 
prior to analysis. The ability to extract genotype informa-
tion allows an expanded repertoire of error checks that 
make use of the genotyping calls. Mendelian error detec-
tion, gender estimation and population-based checks, based 
on the genotyping data, can identify sample mix-ups, pedi-
gree misspecifications and sample contamination. We now 
describe these in further detail.
Variant calling and Mendelian error checking
HTS analysis usually proceeds through standard pipelines 
such as those described in Altmann et al. (2012), which 
are predicated on single samples. We recommend calling 
samples to be analyzed as a genetic entity (single or multi-
ple families) jointly, as this can increase power to identify 
rare variants. Furthermore, using a family-oriented HTS 
analysis pipeline can also produce Mendelian consistent 
genotype data from HTS data by making use of variant 
callers that incorporate familial information. FamSeq 
(Peng et al. 2013) and PolyMutt (Li et al. 2012) improve 
variant calling by making use of familial information 
while MATE-CLEVER (Marschall et al. 2013) performs 
family aware indel detection and calling. Once HapMap 
SNP genotypes are called, Mendelian error checking 
can be performed via LINKDATAGEN (nuclear family 
Mendelian error checks) or through even more sensitive 
Mendelian error detection programs such as PEDCHECK 
(O’Connell and Weeks 1998) and sophisticated pedigree 
misspecification analysis such as PREST (Sun et al. 2002) 
where Mendelian errors are utilized to check specified 
pedigree relationships. LINKDATAGEN also includes a 
population-based test for samples that assesses the fit of 
the three classes of genotype calls (homozygous refer-
ence, heterozygote, homozygous non-reference allele) 
against the expected values for all known HapMap popu-
lations. This test not only highlights whether an assumed 
population is correct but can also detect sample contami-
nation that can occur with HTS data.
Further error checking is performed by specific linkage 
analysis and IBD sharing programs that can detect errors 
or incorporate errors into analysis. This is more important 
for HTS-generated genotypes since genotyping errors can 
be much higher than for SNP chip-derived genotyping data. 
The error rates depend on the thresholds placed on called 
variants that have to be set taking into account the median 
coverages achieved in the family study and the robustness 
of the following analyses to genotyping errors. Further 
error checks using probabilistic approaches make use of 
expected versus observed recombination events, such as 
those implemented in MERLIN (Abecasis et al. 2002), and 
are able to detect additional genotyping errors that can also 
be removed.
One important benefit of linkage analyses in families is 
that more missingness and error can be tolerated than in 
pairwise IBD analysis since much information can be often 
Table 1  HapMap SNPs available for linkage and IBD analysis based on ≥10× average coverage of the targeted regions in at least 50 % of samples
The selected SNPs are over the four HapMap Phase II populations (designated by a _2) and the eleven HapMap Phase III populations (desig-
nated by _3). Data is based on the analysis of 20 Agilent V5 + UTR WES captured samples that were sequenced with Illumina HiSeq 2000 
sequencing at the Australian Genome Research Facility, Melbourne, Australia
Population Available SNPs Covered SNPs % of total SNPs Number SNPs with Het >0.3 % of covered SNPs
CEU_2 3801563 153388 4.03 50231 32.75
CHB_2 3827537 153484 4.01 47498 30.95
JPT_2 3827726 153689 4.02 47351 30.81
YRI_2 3750555 152239 4.06 51241 33.66
CEU_3 1520715 88970 5.85 39174 44.03
ASW_3 1463106 83303 5.69 41279 49.55
CHB_3 1519591 88653 5.83 36806 41.52
CHD_3 1246085 69281 5.56 35887 51.80
GIH_3 1337706 74005 5.53 39370 53.20
JPT_3 1518437 88455 5.83 36720 41.51
LWK_3 1440446 83045 5.77 39271 47.29
MEX_3 1380212 79198 5.74 38910 49.13
MKK_3 1451099 81916 5.65 40321 49.22
TSI_3 1347642 74645 5.54 38875 52.08
YRI_3 1520811 89382 5.88 39684 44.40
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imputed, with little uncertainty. We performed an analysis 
on a pedigree of 15 WES samples with a high level of miss-
ingness (median of medians of coverage 3, range [2, 9]) 
due to poor WES data generation, yet we were still able to 
detect a linkage peak and rapidly identify the causal variant 
despite the inability to identify the variant in many samples 
due to low coverage (Eggers et al. 2014).
IBD and linkage analyses
IBD analyses are usually performed pairwise, either with 
known or unknown relationships between the two individu-
als. IBD analysis is often performed agnostic to the disease 
status, although a typical application is to assess IBD shar-
ing between affected individuals. In the case of a known 
relationship between a pair of individuals IBD calculations 
simply calculate the probability of the observed genotyp-
ing data given the relationship, where the number of mei-
oses separating the two individuals determines the rate of 
change of the underlying (hidden) IBD process. IBD can 
be calculated as a genome-wide summary, or at specified 
locations in the genome. In contrast, linkage analysis is a 
likelihood ratio test statistic that compares the probability 
of the genotyping data, for possibly more than two indi-
viduals, under two different hypotheses. The null hypoth-
esis calculates the probability of the data assuming no link-
age between the phenotype (modeled as another genetic 
marker) and the genotyping data from many genetic mark-
ers, and compares it to the alternative hypothesis of linkage 
between the phenotype and the set of genetic markers. This 
function of the likelihood ratio is known as the LOD score 
and can be calculated at any position in the genome.
Linkage and IBD analyses are powerful approaches for 
the identification of genomic regions harboring the causal 
variants for Mendelian diseases. Thus, both linkage and 
IBD methods are useful tools for filtering detected vari-
ants in cohorts of related individuals with HTS data. To 
implement this, one performs IBD or linkage analysis as 
described above, with or without SNP chip data, prior to 
variant filtering. These regions are then used as an addi-
tional filter for variants that remain to be considered. 
Other authors have designed genetic model-specific hid-
den Markov models for IBD detection (Eggers et al. 2014; 
Krawitz et al. 2010; Roach et al. 2010; Rodelsperger et al. 
2011). For autozygosity mapping some authors have made 
use of simple homozygous run searches, focusing their 
search in these regions (Bilguvar et al. 2010). Extracting 
HapMap SNPs and their genotypes from HTS data allows a 
much broader usage of SNP genotypes derived from these 
studies and enables the use of well-understood statistical 
models and existing algorithms and software for IBD and 
linkage analyses (Tsoi et al. 2014).
Linkage analysis not only identifies linkage regions but 
allows post hoc analysis of the best inferred haplotypes, 
generated by programs such as MERLIN. This is achieved 
with graphical software such as HaploPainter (Thiele and 
Nurnberg 2005), by examining regions of interest. Indi-
viduals that violate the assumed genetic model can be 
identified, such as phenocopies or incompletely penetrant 
individuals. Once a susceptibility haplotype is identified, 
it is then possible to filter the variants based on matching 
of the genotypes called for the variant to the susceptibil-
ity haplotype status, rather than the underlying genotypes 
proposed by the original phenotype. An example of where 
such an approach is valuable is a dominantly inherited phe-
notype with age-dependent penetrance, but fully penetrant 
otherwise. Consider a younger, unaffected individual. This 
individual is identified as having the susceptibility haplo-
type, based on the linkage analysis. Thus, if this individual 
is sequenced it is appropriate to seek variants that are het-
erozygous for this individual. However, for most rare dis-
eases the phenotype and susceptibility haplotype carrier 
status will match the hypothesized genetic model. If the 
WES data is poor, resulting in high levels of missingness, 
it is important to acknowledge that the inferred haplotypes 
conditional on the data will likely be non-unique, thus sam-
pling from the posterior probability and examining a few 
sets of haplotypes is a useful supplementary approach. This 
can be achieved using the --sample option in MERLIN. 
We used this approach in Eggers et al. (2014) to verify 
the robustness, or lack thereof, of the inferred haplotypes. 
The uncertainty in the haplotypes does not have as much 
impact on the calculation of the LOD scores since these are 
summed over all possible haplotypic states that fit the data.
With the advent of dense SNP genotyping data, such as 
that observable in SNP chip or HTS data, it is possible to 
detect relatedness between individuals (Purcell et al. 2007), 
without prior genealogical information, including the 
presence of consanguinity (Albrechtsen et al. 2009; Leu-
tenegger et al. 2006). This relatedness inference can then 
be included in subsequent linkage or IBD analysis (Guer-
gueltcheva et al. 2012; Ivanov et al. 2014). For a review of 
methods that are applicable for this problem see Browning 
and Browning (2012).
We, and others, have successfully applied this approach 
to HTS data, detecting inbreeding and thus making power-
ful use of small families (Browning and Browning 2012; 
Guergueltcheva et al. 2012; Smith et al. 2012, 2013). The 
identification of autozygous regions, even after discovery 
of rare or novel homozygous variants, help to provide fur-
ther evidence that the variants are in fact causal with vari-
ants that are merely homozygous by state and not homozy-
gous by descent (autozygous) being able to be filtered out.
The methods outlined here use IBD analysis to lead to 
a discretized, independent filter of variants. Ideally, one 
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would like to utilize the IBD information as weights rather 
than this discretized approach. Two recently published 
methods are the first to describe such approaches (Koboldt 
et al. 2014; Santoni et al. 2014). This will be useful in fami-
lies where the genetic model is uncertain due to incomplete 
penetrance or possible phenocopies and vital for studies 
and pedigrees where strict Mendelian inheritance does not 
apply.
Compound heterozygote filtering in recessive diseases
Once a region of interest has been identified and the haplo-
typic status of the sequenced affected and unaffected indi-
viduals ascertained, it may be possible to further interro-
gate variants under certain genetic models. One such model 
is the recessive compound heterozygote model where 
affected individuals have inherited one defective allele 
from each parent; one located on a maternally derived hap-
lotype, and the other defective allele located on a paternally 
inherited haplotype. Thus, any two causal alleles need to be 
in ‘trans’, that is, on different haplotypes within the same 
gene. Genes that only contain rare or novel variants that are 
all in ‘cis’ may then be filtered out. This can be assessed in 
two ways.
The first method is contingent on the availability of 
parental genotypes and allows the phasing of each vari-
ant using the trio approach where one checks that each 
of the two variants being interrogated is from one parent 
precisely. This can be done using a simple SNP by SNP 
approach or can be performed using inference of inher-
ited haplotypes to infer where recombinations between 
grandparental haplotypes have taken place. This requires 
a hidden Markov Model that allows for linkage disequilib-
rium and has been implemented using a population-based 
approach by Delaneau et al. (2013) for HTS data and in a 
family-based approach in MERLIN (Abecasis and Wiggin-
ton 2005), for genotyping data processed with LINKDATA-
GEN. These two methods can be used even in the absence 
of parental data. The Delaneau et al. (2013) method uses a 
property of HTS data: each read and read-pair fragment is 
a mini haplotype and these mini-haplotypes can be strung 
together (assembled), similar to de novo assembly, to 
inform whether variants are in the desired ‘trans’ or incor-
rect ‘cis’ state. This method is useful when parental infor-
mation is absent, or only partially available, and thus unin-
formative for haplotype of origin based on the SNP by SNP 
phasing in trios method already described. To implement 
the method one can use the ReadBackedPhasing tool from 
the GATK toolkit (DePristo et al. 2011), HapCUT (Bansal 
and Bafna 2008) or HapCompass (Aguiar and Istrail 2012). 
The likelihood of homozygous parents is small for rare 
variants but is likely to also be more important when the 
individuals are from populations underrepresented in vari-
ant databases, where more of these types of variants will be 
observed.
More unusual sources of genetic variation
Standard HTS pipelines call single-nucleotide variants 
(SNVs) and small indels only (those that can be detected 
with a simple HTS analysis pipeline). The identification 
of moderate-sized indels require additional analysis of the 
HTS data with specialized algorithms such as Pindel (Ye 
et al. 2009). Analysis of larger CNVs also require nonstand-
ard pipeline analysis, since they depend either solely or at 
least partially on depth of coverage (Alkan et al. 2011). 
The detection of structural variation other than CNVs, for 
example translocations, is also possible (Chen et al. 2009). 
All of these variants can be heritable and causal for genetic 
disorders. The identification of IBD regions or linkage 
regions can indicate where standard pipelines have prob-
ably failed or need to be enhanced by looking for these 
alternative, less common, sources of disease causing vari-
ants. Many of these detection methods are still under devel-
opment or prone to false positives and negatives, thus will 
benefit from fine tuning such as that afforded by being able 
to focus on specific genomic regions.
Caveats of family‑based filtering
While rare, it is possible that the assumed genetic model, 
under which the linkage or IBD analysis has been per-
formed, may not be correct. This would lead to an incor-
rect filter. This can occur and is of particular concern for 
consanguineous pedigrees where it is usual to infer an 
autozygous recessive model. However, the inbreeding may 
be a coincidence, with the true mutation being most likely 
an incompletely penetrant dominant mutation or two com-
pound heterozygous recessive mutations. The deeper the 
inbreeding loop, the less likely it is that an affected individ-
ual will still share a segment of an ancestor that is homozy-
gous by descent, as indicated by an increasing LOD score 
for such regions in affected individuals, as parents are more 
distantly related. Extensive inbreeding may also make map-
ping results difficult to interpret, especially in the presence 
of locus heterogeneity (Markus et al. 2012).
The trio design for HTS projects is an extremely attrac-
tive approach for detecting hypothesized de novo variants 
in a cohort of sporadic cases where DNA from both par-
ents is available. Without additional evidence for inbreed-
ing in the population of origin, which suggests the pos-
sibilities of an autozygously inherited variant, the de 
novo genetic model is the most likely genetic model for 
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singleton affected individuals and provides a powerful 
filter for variants. The trio design for de novo analysis is 
another family-based study design but it does not make 
use of linkage information, instead using the family data 
to eliminate inherited variants. Again, however, the success 
of this approach relies heavily on the hypothesized inherit-
ance model being correct. In Taft et al. (2013), the initially 
hypothesized de novo genetic model was proven incorrect, 
with the discovery of two causal variants constituting a 
compound recessive model. However, if a de novo model 
is true, a linkage-based strategy would remove the causal 
variant from consideration as it constitutes a Mendelian 
error. This is the danger of using sporadics or even small 
families: occasionally the proposed genetic model may be 
incorrect. Thus, we propose that if de novo discovery fails 
both an autozygous mapping strategy and a compound het-
erozygote filtering model are applied. In addition, a linkage 
analysis can be performed with unaffected siblings. One 
unaffected sibling in a linkage analysis with a recessive 
model will remove ¼ of the genome from consideration, in 
the absence of inbreeding.
Conclusions
Here, we have shown how IBD sharing analysis can be 
used in tandem with HTS to ensure data veracity, to iden-
tify appropriate genetic models that facilitate genotype 
filtering and to make inferences about which individuals 
are likely to share the ancestral susceptibility haplotype 
according to the best-fitting genetic model at each locus.
HTS is increasingly being applied to high morbid-
ity, rare, Mendelian disorders where only sporadic cases 
are observed due to individuals being unlikely, or unable, 
to reproduce. These types of cohorts usually lack familial 
information for linkage or IBD studies available, unless 
the affected individuals are the product of a consanguine-
ous union, in which case a powerful linkage analysis is 
possible. Other studies can only avail themselves to small, 
underpowered pedigrees for linkage, however, there is no 
longer a requirement for a priori statistically significant 
linkage, since WES and WGS are genome-wide variant 
identification methods, with no additional costs involved to 
examine further regions in the genome. A filter based on 
using multiple regions identified by either linkage or IBD 
analysis can still be a powerful method for the reduction of 
the number of candidate variants.
Many of the approaches we have outlined will become 
even more powerful as WGS supersedes WES and other 
targeted sequencing approaches. WGS is known to have 
less bias overall than WES and thus may identify causal 
variants that have been missed with WES (Bamshad et al. 
2011). WGS will enable the genotype calling for many of 
the HapMap SNPs that can be further supplemented with 
1000 Genome SNPs and SNVs leading towards the ulti-
mate SNP chip. This will also lead to an increased ability 
to uniformly sample SNPs derived from HTS data, further 
improving linkage and IBD approaches.
HTS is not fail-safe. True causal variants may fail to 
be detected due to insufficient coverage or erroneous data 
(Koboldt et al. 2010). Current practice now sees cover-
age assessments for known genes post-WES and targeted 
capture screens of known disease causing genes (Carvill 
et al. 2013). Different laboratories use different criteria by 
which to ascribe success in a gene hunting effort. Hence, it 
is very difficult to know the failure rate of current studies 
with varying reports of success and even more difficult to 
determine false positive rates. It is important to delineate 
between the discoveries of novel genes versus novel vari-
ants in known genes. The latter solves a family but does 
not constitute a new basic research finding of high impact, 
yet it is an important clinical diagnostic success. Research-
ers searching for novel genes for disorders in cohorts of 
patients that have already undergone unsuccessful targeted 
sequencing for known genes have a much lower chance of 
success in finding a causal variant but are more likely to 
make a high impact research finding once the genetic cause 
of disease is identified. Thus, IBD and linkage approaches 
are likely to play a more crucial role in novel gene discov-
ery, however, even targeted approaches will benefit from 
QC methodology that allows inference on relatedness and 
the detection of sample swaps and contamination.
The forthcoming improvements in HTS will lead to 
increased read length. These will improve our capacity 
to infer CNVs, microsatellites, other structural variations 
and facilitate de novo assembly and in silico haplotyping, 
which we have described above to also aid variant filter-
ing. Detection of these types of variants in HTS data will 
also benefit from the use of family-based information. Pen-
nCNV (Wang et al. 2007) utilizes trio and quartet pedigree 
information to improve CNV calls for Illumina and Affy-
metrix SNP chip data and is currently being extended to 
HTS. Similarly, FamSeq (Peng et al. 2013) and PolyMutt 
(Li et al. 2012) improve variant calling by making use of 
familial information.
With the decreasing costs of HTS larger cohorts of 
affected individuals will be sequenced and some of these 
individuals will be related, either cryptically or by a known 
pedigree. Despite the undoubted success of HTS studies, 
the incorporation of familial information has the potential 
to enhance our efforts in this fast-moving field.
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